90 related articles for article (PubMed ID: 3158319)
1. Vasodilative effect of nicorandil on coronary artery.
Miyazaki Y; Ogawa K; Satake T; Sugiyama S; Ozawa T
Arzneimittelforschung; 1985; 35(2):504-7. PubMed ID: 3158319
[TBL] [Abstract][Full Text] [Related]
2. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
Pérez-Vizcaíno F; Cogolludo AL; Villamor E; Tamargo J
Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012
[TBL] [Abstract][Full Text] [Related]
3. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
[TBL] [Abstract][Full Text] [Related]
4. Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.
Matsui K; Ogawa Y; Imai S
Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):124-33. PubMed ID: 2948465
[TBL] [Abstract][Full Text] [Related]
5. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
Abe S; Nishimura J; Nakamura M; Kanaide H
J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
[TBL] [Abstract][Full Text] [Related]
6. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
Magnon M; Durand I; Cavero I
J Pharmacol Exp Ther; 1994 Mar; 268(3):1411-8. PubMed ID: 7908056
[TBL] [Abstract][Full Text] [Related]
7. Effects of 4-aminopyridine and tetraethylammonium on relaxant responses of isolated dog coronary arteries to 2-nicotinamidoethyl nitrate (SG-75).
Sakanashi M; Rokutanda M; Takeo S; Higuchi M
Jpn Heart J; 1982 Mar; 23(2):227-33. PubMed ID: 6210787
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries.
Fujioka H; Ayajiki K; Shinozaki K; Toda N; Okamura T
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):488-95. PubMed ID: 12382080
[TBL] [Abstract][Full Text] [Related]
9. Relaxant effect of nicorandil on the tonic contraction of the canine large coronary artery induced by phorbol 12,13-dibutylate.
Kuromaru O; Sakai K
Arch Int Pharmacodyn Ther; 1995; 330(1):25-38. PubMed ID: 8849308
[TBL] [Abstract][Full Text] [Related]
10. Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo.
Hirata Y; Kanada A; Miyai H; Mabuchi Y; Aisaka K
Arzneimittelforschung; 1999 Mar; 49(3):199-206. PubMed ID: 10219462
[TBL] [Abstract][Full Text] [Related]
11. Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.
Toda N
Br J Pharmacol; 1984 Oct; 83(2):399-408. PubMed ID: 6435709
[TBL] [Abstract][Full Text] [Related]
12. Effects of nicorandil on the conductive coronary artery of the dog.
Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in the vasorelaxant effects of nicorandil and amlodipine on isolated porcine coronary arteries.
Tankó LB; Mikkelsen EO; Frøbert O; Bagger JP
Fundam Clin Pharmacol; 1998; 12(1):50-7. PubMed ID: 9523184
[TBL] [Abstract][Full Text] [Related]
14. The group at C2 of N-ethylnicotinamide determines the vasodilator potencies and mechanisms of action of nicorandil and its congeners in canine coronary arteries.
Satoh K; Yamada H; Yoneyama F; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):589-95. PubMed ID: 1839805
[TBL] [Abstract][Full Text] [Related]
15. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
Sakaino N; Araki H; Nishi K
Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
[TBL] [Abstract][Full Text] [Related]
16. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.
Kukovetz WR; Holzmann S; Braida C; Pöch G
J Cardiovasc Pharmacol; 1991 Apr; 17(4):627-33. PubMed ID: 1711631
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of relaxant effects of nicorandil on the dog coronary artery.
Imai S; Ushijima T; Nakazawa M; Nabata H; Sakai K
Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):274-82. PubMed ID: 6228201
[TBL] [Abstract][Full Text] [Related]
18. Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivity to calcium entry blockade by nifedipine.
Godfraind T; Finet M; Lima JS; Miller RC
J Pharmacol Exp Ther; 1984 Aug; 230(2):514-8. PubMed ID: 6589392
[TBL] [Abstract][Full Text] [Related]
19. Mode of cerebral vasodilating action of KC-404 in isolated canine basilar artery.
Ohashi M; Kito J; Nishino K
Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):216-29. PubMed ID: 3087305
[TBL] [Abstract][Full Text] [Related]
20. Trimethaphan is a direct arterial vasodilator and an alpha-adrenoceptor antagonist.
Harioka T; Hatano Y; Mori K; Toda N
Anesth Analg; 1984 Mar; 63(3):290-6. PubMed ID: 6142667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
